Proactive Management

SB Life Science believes that exceptional management is crucial to the success of a life sciences start-up. Therefore, SB Life Science aims to be an active value-adding investor in its portfolio companies at an early stage by actively participating as a board member or observer.

The Fund’s management team has extensive experience in management consulting, start-up financing and creation, board participation and cross border business development. The combination of the team’s venture capital/technical experience as well as their Asian business network, provides a unique perspective and resource for portfolio companies.

Cross Border Linkage

SB Life Science is committed to creating new life sciences business opportunities in Asia, especially in Japan. Although Japan is recognized as the world’s second largest pharmaceutical market, deal making across the Pacific has been limited because of the differences in business practice, culture and communication. Improved access to this enormous market would result in valuable opportunities for companies seeking additional financing, as well as R&D and marketing partnerships.

SB Life Science’s management team is highly experienced with and well connected to industries in Japan. The team has provided portfolio companies with immensely valuable advice on their business development strategies and assisted with their implementation in Japan. SB Life Science can also leverage on its dedicated local team based in Tokyo, which facilitates communication between portfolio companies and potential local partners.

It is important to note that SB Life Science is the only life sciences venture capital fund backed by prominent institutional and corporate investors from Japan, all of which have significant local business networks. SB Life Science’s investors could potentially become corporate partners or could help make the connection with other prominent companies within their network.